EC Number   |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
|---|
   3.4.17.20 | 754518 |
Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different invitro models |
J. Thromb. Haemost. |
16 |
2057-2069 |
2018 |
Homo sapiens |
30053349 |
| 3.4.17.20 | 754521 |
Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis |
J. Thromb. Haemost. |
17 |
878-884 |
2019 |
Homo sapiens |
30887647 |
| 3.4.17.20 | 755576 |
Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis |
Thromb. Haemost. |
117 |
1498-1508 |
2017 |
Homo sapiens |
28692110 |
| 3.4.17.20 | 754511 |
Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction |
J. Thromb. Haemost. |
13 |
2227-2232 |
2015 |
Homo sapiens |
26340515 |
| 3.4.17.20 | 670058 |
A new functional assay of thrombin activatable fibrinolysis inhibitor |
J. Thromb. Haemost. |
3 |
1284-1292 |
2005 |
Homo sapiens |
15946219 |
| 3.4.17.20 | 701278 |
Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels |
Thromb. Haemost. |
100 |
38-44 |
2008 |
Homo sapiens |
18612536 |
| 3.4.17.20 | 28942 |
Activation and characterization of procarboxypeptidase B from human plasma |
Biochemistry |
34 |
5811-5816 |
1995 |
Homo sapiens |
7727441 |
| 3.4.17.20 | 28934 |
Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C |
J. Biol. Chem. |
273 |
12135-12139 |
1998 |
Homo sapiens |
9575159 |
| 3.4.17.20 | 670466 |
Active carboxypeptidase B is present in free form in serum from patients with acute pancreatitis |
Pancreatology |
5 |
530-536 |
2005 |
Homo sapiens |
16110251 |
| 3.4.17.20 | 652361 |
Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation |
J. Biol. Chem. |
277 |
9944-9951 |
2002 |
Homo sapiens |
11786552 |
